# Angelika Eggert

Source: https://onco.cc/people/angelika-eggert/  
OnCo record `angelika-eggert` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Angelika Eggert is a paediatric oncologist and neuroblastoma researcher.

## Summary

Angelika Eggert is Director of the Department of Pediatric Oncology and Hematology at Charité Universitätsmedizin Berlin. A paediatric oncologist, her specialisms are neuroblastoma, paediatric oncology and tumour biology. She studies neuroblastoma biology, including Trk receptor signalling and risk-adapted therapy. Her papers include a Nature Communications study of spatial and temporal intratumour heterogeneity and its consequences for treatment decisions based on a single biopsy, a study showing neuroblastoma cells depend on HDAC11 for mitotic progression, and the randomised GPOH trial NB2004-HR, which tested extended induction chemotherapy in high-risk neuroblastoma. Her publications are listed on PubMed.

## Fields

- Kind: Person
- Last checked: 2026-09-08
- Role: Director, Department of Pediatric Oncology and Hematology, Charité
- Specialisms: Neuroblastoma; Paediatric oncology; Tumour biology

## Sources

- PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=Eggert%20A%5BAuthor%5D%20neuroblastoma

## Connected records

- cancers: [Neuroblastoma (paediatric)](https://onco.cc/cancers/neuroblastoma/)
- institutions: [Charité Universitätsmedizin Berlin](https://onco.cc/institutions/charite/)
- ideas: [Develop drugs in children first when the target is a children's target](https://onco.cc/ideas/idea-bio2-paediatric-first-development/)

---
JSON: https://onco.cc/api/v1/entities/angelika-eggert.json